Article tools
Author information

Research Article

Defective expression of p56lck in an infant with severe combined immunodeficiency.

F D Goldman, Z K Ballas, B C Schutte, J Kemp, C Hollenback, N Noraz and N Taylor

Department of Pediatrics, University of Iowa, Iowa City, Iowa 52242, USA. frederick-goldman@uiowa.edu

Published July 15, 1998

Severe combined immune deficiency (SCID) is a heterogeneous disorder characterized by profound defects in cellular and humoral immunity. We report here an infant with clinical and laboratory features of SCID and selective CD4 lymphopenia and lack of CD28 expression on CD8(+) T cells. T cells from this patient showed poor blastogenic responses to various mitogens and IL-2. Other T cell antigen receptor- induced responses, including upregulation of CD69, were similarly inhibited. However, more proximal T cell antigen receptor signaling events, such as anti-CD3 induced protein tyrosine phosphorylation, phosphorylation of mitogen-associated protein kinase, and calcium mobilization were intact. Although p59fyn and ZAP-70 protein tyrosine kinases were expressed at normal levels, a marked decrease in the level of p56lck was noted. Furthermore, this decrease was associated with the presence of an alternatively spliced lck transcript lacking the exon 7 kinase encoding domain. These data suggest that a deficiency in p56lck expression can produce a SCID phenotype in humans.

Articles that cite
this article:

Defective dendritic cell maturation in a child with nucleotide excision repair deficiency and CD4 lymphopenia
L. Racioppi, C. Cancrini, M. L. Romiti, F. Angelini, S. Di cesare, E. Bertini, S. Livadiotti, M. G. Gambarara, G. Matarese, F. Lago paz
Clin Exp Immunol 126(3):511. [CrossRef]

Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness
M. V. Ursini, L. Gaetaniello, R. Ambrosio, E. Matrecano, A. J. Apicella, M. C. Salerno, C. Pignata
Clin Exp Immunol 129(3):502. [CrossRef]

Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways
Fabio Candotti, Luigi Notarangelo, Roberta Visconti, John O’shea
J Clin Invest 109(10):1261. [CrossRef]

CD8+CD28- T cells: Certainties and uncertainties of a prevalent human T-cell subset
Fernando A Arosa
Immunol Cell Biol 80(1):1. [CrossRef]

Molecular defects in T- and B-cell primary immunodeficiency diseases
Charlotte Cunningham-rundles, Prashant P. Ponda
Nat Rev Immunol 5(11):880. [CrossRef]

Selective tyrosine kinase inhibitors
Sandra E Wilkinson, William Harris
eoed 5(3):287. [CrossRef]

Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency
Tuba Turul, Ilhan Tezcan, Hasibe Artac, Sandra Bruin-versteeg, Barbara H. Barendregt, Ismail Reisli, Ozden Sanal, Jacques J. M. Dongen, Mirjam Burg
Eur J Pediatr 168(1):87. [CrossRef]